Phase 2a Study of Baxdrostat in Primary Aldosteronism
A
Adina F. Turcu
(University of Michigan, Ann Arbor)
M
Mason W. Freeman
(Harvard Medical School, Boston)
I
Irina Bancos
(Mayo Clinic, Rochester, MN)
A
Anat Ben-Shlomo
(Cedars–Sinai Medical Center, Los Angeles)
O
Oksana Hamidi
(University of Texas Southwestern Medical Center, Dallas)
A
Amir H. Hamrahian
(Johns Hopkins University, Baltimore)
W
Wenyu Huang
L
Lawrence S. Kirschner
(Ohio State University Wexner Medical Center, Columbus)
R
Ramin Sam
(University of California, San Francisco, San Francisco)
A
Ashwini Mallappa
(AstraZeneca, Gaithersburg, MD)
B
Bonifride Tuyishimire
(AstraZeneca, Gaithersburg, MD)
A
Aina S. Lihn
(AstraZeneca, Gothenburg, Sweden)
S
Shira Perl
(AstraZeneca, Gaithersburg, MD)
M
Morris J. Brown
(Queen Mary University of London, London)
Article Details
Journal
New England Journal of Medicine
Volume / Issue
Vol. 393, Issue 5
Published
July 31, 2025
Pages
515-518
ISSN
0028-4793
Publisher
Massachusetts Medical Society
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
ISSN: 0028-4793 Social Sciences
Authors (14)
A
Adina F. Turcu
University of Michigan, Ann Arbor
M
Mason W. Freeman
Harvard Medical School, Boston
I
Irina Bancos
Mayo Clinic, Rochester, MN
A
Anat Ben-Shlomo
Cedars–Sinai Medical Center, Los Angeles
O
Oksana Hamidi
University of Texas Southwestern Medical Center, Dallas
A
Amir H. Hamrahian
Johns Hopkins University, Baltimore
W
Wenyu Huang
L
Lawrence S. Kirschner
Ohio State University Wexner Medical Center, Columbus
R
Ramin Sam
University of California, San Francisco, San Francisco
A
Ashwini Mallappa
AstraZeneca, Gaithersburg, MD
B
Bonifride Tuyishimire
AstraZeneca, Gaithersburg, MD
A
Aina S. Lihn
AstraZeneca, Gothenburg, Sweden
S
Shira Perl
AstraZeneca, Gaithersburg, MD
M
Morris J. Brown
Queen Mary University of London, London
Related Articles from this Journal
Doctor’s Dirty Little Secret — The Cost of Silence
Tara Khan
Aug 2026
10.1056/nejmp2515506
Obstructive Hypertrophic Cardiomyopathy
Julian-Kai Nishizono, Marohito Nakata
Aug 2026
10.1056/nejmicm2603868
T-Cell Engager–Mediated HLA Antibody Depletion before Kidney Transplantation
Martina Schatzl, Katharina A. Mayer et al.
Jul 2026
10.1056/nejmc2603853
Products That Pose Health Risks — Can Litigation Protect Us When Government Fails?
Jerry Avorn
Jul 2026
10.1056/nejmp2604841
Precision Intensification in Metastatic Prostate Cancer
Rana R. McKay
Jul 2026
10.1056/nejme2605582